Integrated Diagnostics Holding Plc. (IDH or the Company) is a leading diagnostic service provider in the Middle East and Africa (MEA) region offering pathology and radiology services in Egypt, Jordan, Sudan and Nigeria. The Company has a 40-year track record and is a trusted and quality provider of diagnostics services with internationally recognized accreditations (ISO, CAP and JCI). IDH offers over 2,000 diagnostic tests under 7 key brands with strong reputation in underserved markets. As of September 30, 2020, IDH has a network of 471 branches and employs over 5,500 employees across its geographic footprint. IDH is a Jersey registered public limited company listed on the London Stock Exchange (LSE) since May 2015. IDHs investment plans include expansion plans in Egypt and new acquisitions and greenfield investments in other emerging markets as well as achieving a dual listing of its shares on the Egyptian Stock Exchange (EGX) (the Project).

(i) IFC is supporting IDH in becoming the first healthcare provider in MEA to seek the EDGE Gender Equality Certification, in efforts to create a gender-equal workplace; and

(ii) Through the implementation of the IFC healthcare quality advisory, IFC is supporting IDH to overcome any quality and patient safety challenges in its radiology operations, to support IDHs aim of becoming the first stand-alone radiology facility to receive American College of Radiology (ACR) accreditation in Egypt.